Expert Interview
Reviewing the FDA Breakthrough Device Designation for Roche's Elecsys® Amyloid Plasma Panel for Alzheimer's Disease detection
Ticker(s): RHHBY, LLYInstitution: Private Practice
- Neurologist in private practice in CA with over 25 years of clinical experience.
- Currently manages 100 patients with Alzheimer's disease.
- Diplomat of the American Board of Psychiatry; fellowship trained in Neuromuscular Physiology at UCSF.
Describe your background and practice setting
How many patients with Alzheimer's disease do you manage?
Added By: ben_adminWhat is the gold standard for Alzheimer's diagnosis currently?
Added By: ben_adminWhat is your opinion on the potential of Roche's Amyloid Plasma Panel?
Added By: ben_adminWhat patients would you order this panel for?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
